Search

everythinglearnresearchcommunity

for

Search:↓

Some skin medications can have harmful interactions with the COVID-19 drug nirmatrelvir-ritonavir, but not with molnupiravir.

Ocrelizumab helped control lupus in a pregnant patient, leading to the birth of a healthy baby.

The new Brigatinib nanocarrier is more effective against lung cancer cells than the free drug.

Using Decamethoxine and Blastomunil together speeds up wound healing.

Cancer patients have lower immunity and higher virus and zinc levels in their hair.

Ritlecitinib and baricitinib are similarly effective for hair regrowth in severe alopecia areata.

Vorasidenib can cause unusual hair growth.

Guduchi and Yashtimadhu can reduce chemotherapy side effects.

Surgical excision is the best treatment for SCC, but intralesional cidofovir might be a good alternative.

No method fully prevents hair loss from chemotherapy, but some methods can reduce it and improve quality of life.

A new peptide, murikal/SPR4, was found to significantly increase hair growth in mice, and its liposomal topical formulations enhanced hair growth more than commercial products. However, results on human scalp skin were unclear, needing more tests.

Aumolertinib effectively controls lung cancer and improves quality of life.

Three children with nasal fungal infections were successfully treated with potassium iodide and sometimes itraconazole.

Topical thiols may prevent hair loss caused by certain chemotherapy drugs.

A woman with severe hair loss was successfully treated with the drug adalimumab.

Tofacitinib helped improve symptoms and hair growth in a patient with Aicardi-Goutières syndrome.

PLD is an effective and safer alternative for treating breast cancer.

Methotrexate effectively controls eye inflammation in Japanese patients with non-infectious uveitis but requires careful monitoring for side effects.

Tofacitinib effectively regrew scalp hair in an 11-year-old girl with alopecia areata.

Tofacitinib, a JAK inhibitor, improved hair regrowth in most patients with severe alopecia areata and had minimal side effects.

LGD1069 effectively prevents breast tumors in mice without toxicity.

Tofacitinib and methotrexate successfully treated a woman's severe skin, joint, and hair loss issues.

The document concludes that pregnancy and cancer share immune evasion tactics, but more research is needed before using checkpoint blockade immunotherapy in pregnant cancer patients to avoid harm to the placenta.

Baricitinib is effective and cost-efficient for treating severe alopecia areata in adults.

The treatment combination is effective and generally safe for lung cancer.

MK-0773 safely increased muscle mass but did not improve muscle strength or function in elderly women with sarcopenia.

Standard dosing is more effective for severe alopecia areata in children, but unorthodox dosing can be safe and considered if needed.

Tumor-targeted drug carriers can improve chemotherapy precision and reduce side effects.

Baricitinib improved hair loss and arthritis in a lupus patient.

Improving how drugs are absorbed through the skin could better treat mange in wombats.